United States · Platforms & data · MarketBeat
Guardant Health's (GH) "Overweight" Rating Reaffirmed at Stephens

Detailed summary
Stephens reissued an "overweight" rating and issued a $210.00 price target on shares of Guardant Health in a research note on Friday.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)




